China Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report Forecast 2017 to 2022

November 2017 | 130 pages | ID: C14D54193A3EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The China Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Glucagon Like Peptide-1 (GLP-1) Agonists industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Glucagon Like Peptide-1 (GLP-1) Agonists market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Novo Nordisk
AstraZeneca
Eli Lilly
GSK
Sanofi
Bristol-Myers Squibb
Amylin
company 8
company 9

China Glucagon Like Peptide-1 (GLP-1) Agonists Market: Product Segment Analysis
Type 1
Type 2
Type 3

China Glucagon Like Peptide-1 (GLP-1) Agonists Market: Application Segment Analysis
Hospital
Pharmacy
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET OVERVIEW

1.1 Product Overview and Scope of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation by Type
  1.2.1 China Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation by Application
  1.3.1 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application in 2016
  1.3.2 Hospital
  1.3.3 Pharmacy
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Glucagon Like Peptide-1 (GLP-1) Agonists (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Glucagon Like Peptide-1 (GLP-1) Agonists Industry

CHAPTER 3 CHINA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET COMPETITION BY MANUFACTURERS

3.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Production and Share by Manufacturers (2015 and 2016)
3.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution, Production Area and Product Type
3.5 Glucagon Like Peptide-1 (GLP-1) Agonists Market Competitive Situation and Trends
  3.5.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration Rate
  3.5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production and Growth (2012-2017)
4.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth (2012-2017)
4.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Production and Market Share by Type (2012-2017)
5.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2012-2017)
5.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2012-2017)
5.4 China Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth by Type (2012-2017)

CHAPTER 6 CHINA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET ANALYSIS BY APPLICATION

6.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Market Share by Application (2012-2017)
6.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURERS ANALYSIS

7.1 Novo Nordisk
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 AstraZeneca
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Eli Lilly
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 GSK
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Sanofi
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Bristol-Myers Squibb
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Amylin
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 company
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 company
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURING COST ANALYSIS

8.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET FORECAST (2017-2022)

12.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue Forecast (2017-2022)
12.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption Forecast by Regions (2017-2022)
12.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Production Forecast by Type (2017-2022)
12.4 China Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast by Application (2017-2022)
12.5 Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast (2017-2022)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure China Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2016
Table Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application in 2016
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2021)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Capacity of Key Manufacturers (2015 and 2016)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Capacity of Key Manufacturers in 2015
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Capacity of Key Manufacturers in 2016
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Production of Key Manufacturers (2015 and 2016)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Manufacturers (2015 and 2016)
Figure 2015 Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Manufacturers
Figure 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Production Share by Manufacturers
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers
Table 2016 China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers
Table China Market Glucagon Like Peptide-1 (GLP-1) Agonists Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Glucagon Like Peptide-1 (GLP-1) Agonists Average Price of Key Manufacturers in 2016
Table Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution and Sales Area
Table Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Type
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 3 Manufacturers
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table GSK Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table Amylin Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table company 8 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Figure Production Revenue Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type (2012-2017)
Figure 2015 Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2012-2017)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth by Type (2012-2017)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application (2012-2017)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application (2012-2017)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application in 2016
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth Rate by Application (2012-2017)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
Table Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2015
Table Major Buyers of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Distributors/Traders List
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate Forecast (2017-2022)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Production, Import, Export and Consumption Forecast (2017-2022)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Production Forecast by Type (2017-2022)
Table China Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

Novo Nordisk
AstraZeneca
Eli Lilly
GSK
Sanofi
Bristol-Myers Squibb
Amylin